# Effects of PG2 on Fatigue-Related Symptom Clusters

> **NCT02740959** · NA · COMPLETED · sponsor: **Taipei Medical University** · enrollment: 6 (actual)

## Conditions studied

- Cancer-related Fatigue

## Interventions

- **DRUG:** Astragalus Polysaccharides 500 mg
- **DRUG:** Astragalus Polysaccharides 250 mg

## Key facts

- **NCT ID:** NCT02740959
- **Lead sponsor:** Taipei Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-05-08
- **Final completion:** 2017-05-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740959, "Effects of PG2 on Fatigue-Related Symptom Clusters". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02740959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*